Lactiplantibacillus plantarum BW2013 protects mucosal integrity and modulates gut microbiota of mice with colitis.
Xiaohui NiuQian LiNa LuanJia LiuMichael ZhangJun AnZuming LiXuliang ZhuangRan XiaZhichao WuPublished in: Canadian journal of microbiology (2023)
This study explored the effects of Lactiplantibacillus plantarum (previously Lactobacillus plantarum ) BW2013 on mucosal integrity and gut microbiota of mice with dextran sulfate sodium (DSS)-induced colitis. The results show that the clinical symptoms in DSS-modelled ulcerative colitis (UC) were improved by L. plantarum BW2013 via decreasing disease activity index scores and suppressing inflammatory cell infiltration. Furthermore, L. plantarum BW2013 decreased the levels of diamine oxidase activity, myeloperoxidase, and D-lactic acid. The mRNA expression of ZO-1, occludin, and claudin-1 was upregulated by L. plantarum BW2013, which also increased IL-10 and reduced TNF-α, IL-1β, and IL-6 in the colon. 16S rDNA sequencing showed that L. plantarum BW2013 enhanced α-diversity. L. plantarum BW2013 upregulated significantly the abundance of unidentfied Lachnospiraceae , Lactococcus , Rikenella , Lactobacillus , and Odoribacter , which had an inhibitory effect on inflammation and a protective effect on the integrity of the mucosa. These results demonstrate that L. plantarum BW2013 alleviates DSS-modelled UC by protecting mucosal integrity and ameliorating the composition of gut microbiota.
Keyphrases
- ulcerative colitis
- disease activity
- rheumatoid arthritis
- lactic acid
- systemic lupus erythematosus
- oxidative stress
- single cell
- stem cells
- metabolic syndrome
- signaling pathway
- microbial community
- physical activity
- mesenchymal stem cells
- bone marrow
- juvenile idiopathic arthritis
- skeletal muscle
- depressive symptoms
- high throughput sequencing